Bill Steinkrauss

Chief Financial Officer at ILiAD Biotechnologies

Speaker

Bill Steinkrauss is Chief Financial Officer at ILiAD Biotechnologies. Prior to ILiAD, Bill founded OWL CFO Consulting, a consulting firm providing part-time CFO services to public and private biotechnology companies. Previously, he served as Chief Financial Officer and Chief Administrative Officer of Curis, Inc., a publicly traded biotechnology company. In his experience as CFO, Bill has led various financings that raised over $500 million of proceeds. He previously worked in the finance departments at Ovascience, Inc., and at Cubist Pharmaceuticals, Inc., through its acquisition by Merck in 2015. Prior to joining the biopharma industry, Bill worked within the capital markets advisory and assurance practices at PricewaterhouseCoopers, LLP. He holds a B.S. in accounting and finance and an M.S. in accounting from Boston College. Bill is a certified public accountant.